Paris Saclay Cancer Cluster (PSCC)

About Paris Saclay Cancer Cluster (PSCC)

The Paris Saclay Cancer Cluster (PSCC) is building a world-class biocluster to position France as the leading hub for cancer innovation. Selected by the French authorities as part of the Healthcare Innovation 2030 plan, the PSCC is a non-profit French Foundation for Scientific Cooperation (FCS) with a dual global ambition: ✅ Change the outcome of millions of patients fighting cancer worldwide ✅ Position France and Europe at the forefront of the 1st pharmaceutical industry A world-class ecosystem driving innovation Founded by Gustave Roussy, Sanofi, Inserm, Paris-Saclay University, and the Polytechnic Institute of Paris, the PSCC has rapidly expanded, welcoming key partners such as Unicancer, Institut Curie, AP-HP, and Medicen. With industry sponsors including Sanofi, Servier, GSK, IPSEN, and Merck, we act as a catalyst to transform breakthrough discoveries into industrial diagnostic and therapeutic solutions. To accelerate this transformation, the PSCC provides a thriving environment including: 🔹 A premier location at Campus Grand Parc, Europe's leading cancer innovation hub, offering office/lab spaces with optimal solutions and controlled investment 🔹 Project support, access to mentors, funding, and strategic networks 🔹 Real-world data, biological samples, advanced technological & clinical platforms 🔹 A dynamic network bringing together Researchers, clinicians, startups, biotechs, pharma leaders, CROs, investors, public authorities and patients Key Achievements & Impact 📌 150+ members within PSCC Connect 📌 50+ support companies (CROs, CDMOs, equipment providers, IP experts, etc.) 📌 Implementation at Campus Grand Parc 📌 5 academic platforms funded 📌 Major DATA initiative 📌 60 + projects supported to date, including: -> €118M raised by 13 startups -> 2 startups successfully acquired 🚀 Whether you're a startup, biotech, pharma company, CRO, or investor, join us and accelerate the next generation of cancer innovations!